1 min read
CareMetx Announces Addition of Nasir Ali as Chief Product Officer
Bethesda, Maryland, September 20, 2022 - CareMetx, LLC, a leading technology-enabled services company focused on improving patient access to...
Shift the focus to improving patient experience, care, and practice success
Empower your practice to focus on patient care with streamlined administrative solutions
Get in touch with our team for provider client support
Ensure patients can start and stay on the therapies they need by removing obstacles at every step of their journey
Solution
Resources
Our focus has been deeply rooted in one common theme from the beginning — that patients are the priority
Keep up to date on news and announcements at CareMetx
Join our team
Meet with us
1 min read
Bethesda, Maryland, September 20, 2022 - CareMetx, LLC, a leading technology-enabled services company focused on improving patient access to...
1 min read
Kale brings more than 20 years’ experience in healthcare and financial leadership.
2 min read
Jim Rowe joins as President and CEO, bringing more than 20 years of experience in healthcare technology Mark Hansan, Co-founder, to assume Executive...
2 min read
New Strategic Partnership Will Simplify and Accelerate Specialty Medication Access and Adherence
2 min read
Strategic acquisition of leading patient adherence technology and services provider to complement CareMetx current suite of patient access products.
2 min read
CareMetx’s subsidiary OutcomeRx Insurance Management Services,LLC will leverage access to the Emerging Therapy Solutions (ETS) nationwide network of...
New Strategic Partnership Will Simplify and Accelerate Specialty Approval Medication Process
2 min read
CareMetx Announces Acquisition of Phyz Healthcare Solutions, a Digital Healthcare Company The acquisition of Phyz Healthcare Solutions offers clients...
3 min read
CareMetx, General Atlantic and The Vistria Group Announce Strategic Growth Partnership Significant investment from General Atlantic and The Vistria...
5 min read
Launch of new reinsurance product will help payers manage sudden, high costs of therapies for rare genetic diseases with goal of reducing access and...